News and Events

  • Recent Releases

    08/31/2015 - 3:45pm

    Researchers discover marker for rare but lethal eye cancer

    A new marker already linked to other types of cancer was found to play a role in retinoblastoma, a rare but lethal form of cancer. When advanced forms of RB affect both eyes, this cancer causes partial or full loss of vision in about 50 percent of patients. This tumor is normally treated by eye removal or administration of chemotherapy drugs that are often toxic to the normal retina, and thus can jeopardize vision. No targeted therapy, which selectively kills tumor cells but spares normal retinal cells, exists.
    08/24/2015 - 4:00pm

    Fertility concerns impact breast cancer treatment decisions

    Concerns about fertility kept a third of young women with breast cancer from taking tamoxifen, despite its known benefit in reducing the risk of breast cancer coming back.

    08/07/2015 - 9:30am

    Simeone named upcoming chair of Pancreatic Cancer Action Network scientific board

    Diane Simeone, M.D., director of the Pancreatic Cancer Center at the University of Michigan, was recently named the upcoming chair of the National Scientific and Medical Advisory Board for the Pancreatic Cancer Action Network.

    07/28/2015 - 12:00pm

    U-M Breast Oncology Program benefits from QVC presents ‘FFANY Shoes on Sale’

    The University of Michigan Comprehensive Cancer Center’s Breast Oncology Program was one of nine beneficiaries of the 2014 QVC Presents "FFANY Shoes on Sale" event. FFANY and QVC representatives presented a check for $380,000 to the Cancer Center.

    07/15/2015 - 2:45pm

    Rhim receives award from Doris Duke Foundation

    Andrew D. Rhim, M.D., assistant professor of gastroenterology, received a 2015 Clinical Scientist Development Award from the Doris Duke Charitable Foundation to advance research on pancreatic cancer.

    All Releases